- India rejects Bayer Nexavar CL appeal
- India Shuns Onglyza Compulsory License But Lee To Fight On?
- PhRMA keeps eye on Indian compulsory licensing activity
- India Onbrez infringement case: Who said winner takes all?
COMMENT Other Informa Comment
- Interview: Cipla's heiress on taking the legacy forward & the firm's new baby
- Innovation not M&A to drive Bayer growth in LatAm
20 January 2016
PGA National, Palm Beach Gardens, FL
JOB OF THE WEEK Pharmaceuticals / Healthcare – Equity Research Analyst